These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 38445246)
1. Welcome to the Journal of Market Access and Health Policy under MDPI Wings. Toumi M J Mark Access Health Policy; 2024 Mar; 12(1):2-4. PubMed ID: 38445246 [No Abstract] [Full Text] [Related]
2. Publisher's Note: A New Chapter for the Aunós C J Mark Access Health Policy; 2024 Mar; 12(1):1. PubMed ID: 38445245 [No Abstract] [Full Text] [Related]
3. Publisher's Note: Welcome to Roth P Dermatopathology (Basel); 2020 Jun; 7(1):17. PubMed ID: 32608381 [TBL] [Abstract][Full Text] [Related]
4. Steady impact factor growth for MDPI open access journals. Thiesen A Molecules; 2012 Sep; 17(9):10971-3. PubMed ID: 22971582 [TBL] [Abstract][Full Text] [Related]
5. Opening up Peer Review in Life: Towards a Transparent and Reliable Process. Rampelotto PH Life (Basel); 2014 May; 4(2):225-6. PubMed ID: 25370195 [TBL] [Abstract][Full Text] [Related]
6. Introduction to a New Open Access Journal by MDPI: Flahault A Epidemiologia (Basel); 2020 Aug; 1(1):1. PubMed ID: 36417205 [TBL] [Abstract][Full Text] [Related]
7. Publication of Controversial Papers in Life. Lin SK Life (Basel); 2012 Feb; 2(1):213-4. PubMed ID: 26791663 [TBL] [Abstract][Full Text] [Related]
8. Dose-ranging study of salmeterol using a novel fluticasone propionate/salmeterol multidose dry powder inhaler in patients with persistent asthma. Miller DS; Yiu G; Hellriegel ET; Steinfeld J Allergy Asthma Proc; 2016 Jul; 37(4):291-301. PubMed ID: 27216137 [TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics, safety, and tolerability of single, high-strength doses of fluticasone propionate and fluticasone propionate/salmeterol delivered via a novel multidose dry powder inhaler in adolescents and adults with persistent asthma. Nugent C; Yiu G; Song S; Caracta C J Asthma; 2018 Aug; 55(8):898-906. PubMed ID: 28933971 [TBL] [Abstract][Full Text] [Related]
10. Fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers compared with placebo for persistent asthma. Sher LD; Yiu G; Sakov A; Liu S; Caracta CF Allergy Asthma Proc; 2017 Sep; 38(5):343-353. PubMed ID: 28639542 [TBL] [Abstract][Full Text] [Related]
11. Albuterol multidose dry powder inhaler efficacy and safety versus placebo in children with asthma. LaForce C; Taveras H; Iverson H; Shore P Allergy Asthma Proc; 2017 Jan; 38(1):28-37. PubMed ID: 28052799 [TBL] [Abstract][Full Text] [Related]
12. Safety, efficacy, and dose response of fluticasone propionate delivered via the novel MDPI in patients with severe asthma: A randomized, controlled, dose-ranging study. Bernstein DI; Gillespie M; Song S; Steinfeld J J Asthma; 2017 Aug; 54(6):559-569. PubMed ID: 27937064 [TBL] [Abstract][Full Text] [Related]
13. Randomized, dose-ranging study of a fluticasone propionate multidose dry powder inhaler in adolescents and adults with uncontrolled asthma not previously treated with inhaled corticosteroids. Kerwin EM; Gillespie M; Song S; Steinfeld J J Asthma; 2017 Jan; 54(1):89-98. PubMed ID: 27285965 [TBL] [Abstract][Full Text] [Related]
14. Welcome to Journal of Foot and Ankle Research: a new open access journal for foot health professionals. Menz HB; Potter MJ; Borthwick AM; Landorf KB J Foot Ankle Res; 2008 Jul; 1(1):1. PubMed ID: 18822156 [TBL] [Abstract][Full Text] [Related]
15. Resumed Publication of Lin SK; McPhee DJ Pharmaceuticals (Basel); 2009 Apr; 2(1):1. PubMed ID: 27713218 [TBL] [Abstract][Full Text] [Related]
16. The analysis of transgenic apples with down-regulated expression of Tanaka N; Tanaka-Moriya Y; Mimida N; Honda C; Iwanami H; Komori S; Wada M Plant Biotechnol (Tokyo); 2016; 33(5):395-401. PubMed ID: 31275000 [TBL] [Abstract][Full Text] [Related]